U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 4,731 records

Showing results for "secondary".

  1. Neds 2019 Core Maskedstats Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2019_Core_MaskedStats_Weighted.PDF
    January 01, 2019 - 5.93944 PAY1 Primary expected payer (uniform) 33,101,751 45,500 1 6 2.45 0.01 2.42702 2.46891 PAY2 Secondary

  2. Neds 2020 Core Maskedstats Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2020_Core_MaskedStats_Weighted.PDF
    January 01, 2020 - 6.51488 PAY1 Primary expected payer (uniform) 27,988,930 48,104 1 6 2.46 0.01 2.43508 2.47768 PAY2 Secondary

  3. Addendum to HCUP Statistical Brief #309: Racial and Ethnic Differences in Inpatient Stays Involving Sepsis, 2016–2021, Addition of 2022 Data (pdf file)

    hcup-us.ahrq.gov/reports/statbriefs/sb309-sepsis-race-2016-2022-addendum.pdf
    January 01, 2022 - stays when sepsis was a co-occurring condition or complication of the stay (i.e., only reported as a secondary

  4. Institute for the Design of Environments Aligned for Patient Safety (IDEA4PS) | Agency for Healthcare Research and Quality

    www.ahrq.gov/patient-safety/resources/learning-lab/design-environments-long-desc.html
    April 01, 2021 - IDEA4PS's work reduced the alarm burden of bedside monitors and the Secondary Alarm Notification System

  5. Disposition of Comments for CERs 155 156 Contast-Induced Nephropathy (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
    January 07, 2016 - Introduction: The question of whether the diagnosis of "CIN" is really AKI secondary to contrast or … contrast is also likely to be receiving statin therapy (given their widespread using in primary and secondary … However, while the CIN outcome was not included, the investigators chose to use the ACT study for secondary … CIN, was not included in the primary analyses of NAC and CIN (though it seems to be included in a secondary

  6. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/fetal-surgery_disposition-comments.pdf
    July 05, 2011 - fetal mediastinum is compressed, leading to impaired venous return with resulting fetal hydrops secondary … Furthermore, the original UCSF study has lung growth as primary outcome and survival as secondary outcome … , whereas the Brown study has survival as primary and lung growth as secondary; the joint proposal … has survival as primary outcome and lung growth as secondary.

  7. MAINTAIN AND EXPAND (pdf file)

    hcup-us.ahrq.gov/reports/methods/2000NISComparisonReportFinal.pdf
    February 28, 2003 - If a symptom appears as a first-listed code and a diagnosis appears as a secondary code, the diagnosis … If a symptom appears as a first- listed code and a diagnosis is listed as a secondary code, the diagnosis … comparing NIS records to MedPAR, only the NIS discharges for which Medicare was the expected primary or secondary … For example, when a symptom appeared as the first-listed code, it was reassigned as a secondary diagnosis … For researchers interested in discharges for which Medicare is a secondary payer, the NIS is the only

  8. Nis 2011 Maskedstats Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Core_Weighted.PDF
    January 01, 2011 - Statistics Variable Label N N Miss Minimum Maximum Mean Std Error of Mean 95% CL for Mean PAY2 Secondary … OTHER O.R.PROC 5,704 0.01% 409: RADIOTHERAPY 2,411 0.01% 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … 142,269 0.37% 464: SIGNS & SYMPTOMS W/O CC 39,515 0.10% 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 1,187 0.00% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 12,858 0.03% … 0.11% 40: Multiple myeloma 18,248 0.05% 41: Cancer; other and unspecified primary 7,990 0.02% 42: Secondary

  9. Nis 2008 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2008_MaskedStats_Core.PDF
    January 01, 2008 - 1.00 0.30 0.46 PAY1 : Primary expected payer (uniform) 8,144,696 13,685 1.00 6.00 2.23 1.20 PAY2 : Secondary … W OTHER O.R.PROC 1,271 0.02% 409: RADIOTHERAPY 816 0.01% 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 25,774 0.32% 464: SIGNS & SYMPTOMS W/O CC 8,701 0.11% 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 430 0.01% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 4,227 0.05% 467 … 0.11% 40: Multiple myeloma 3,908 0.05% 41: Cancer; other and unspecified primary 1,729 0.02% 42: Secondary

  10. Nis 2006 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Core.PDF
    January 01, 2006 - 30.00 1.55 1.98 PAY1 : Primary expected payer (uniform) 8061232 13593 1.00 6.00 2.22 1.21 PAY2 : Secondary … NEOPL W OTHER O.R.PROC 1171 0.01 409: RADIOTHERAPY 987 0.01 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … W CC 14479 0.18 464: SIGNS & SYMPTOMS W/O CC 4703 0.06 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 501 0.01 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 4812 0.06 467: … diseases) 18336 0.23 98: Essential hypertension 16768 0.21 99: Hypertension with complications and secondary

  11. Nis 2007 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2007_MaskedStats_Core.PDF
    January 01, 2007 - 31.00 1.61 2.02 PAY1 : Primary expected payer (uniform) 8025878 17537 1.00 6.00 2.25 1.21 PAY2 : Secondary … W CC 21944 0.27 464: SIGNS & SYMPTOMS W/O CC 7159 0.09 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 388 0.00 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 4244 0.05 467: … 8769 0.11 40: Multiple myeloma 3631 0.05 41: Cancer; other and unspecified primary 1696 0.02 42: Secondary … Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 99: Hypertension with complications and secondary

  12. Nis 2009 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2009_MaskedStats_Core.PDF
    January 01, 2009 - 1.00 0.29 0.46 PAY1 : Primary expected payer (uniform) 7,794,273 16,489 1.00 6.00 2.21 1.20 PAY2 : Secondary … Distribution for DRG24 DRG24 Frequency Percent of Total 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 26,044 0.33% 464: SIGNS & SYMPTOMS W/O CC 8,109 0.10% 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 274 0.00% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 3,207 0.04% 467 … 0.11% 40: Multiple myeloma 3,623 0.05% 41: Cancer; other and unspecified primary 1,480 0.02% 42: Secondary

  13. Nis 2009 Maskedstats Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2009_MaskedStats_Core_Weighted.PDF
    January 01, 2009 - 0.3008 PAY1 Primary expected payer (uniform) 7,794,273 16,489 1.00 6.00 2.21 0.01 2.1869 2.2353 PAY2 Secondary … Distribution for DRG24 DRG24 Frequency Percent of Total 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … 132,135 0.34% 464: SIGNS & SYMPTOMS W/O CC 41,204 0.10% 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 1,390 0.00% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 16,237 0.04% … 0.11% 40: Multiple myeloma 18,210 0.05% 41: Cancer; other and unspecified primary 7,416 0.02% 42: Secondary

  14. Nis 2010 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2010_MaskedStats_Core.PDF
    January 01, 2010 - 1.00 0.29 0.45 PAY1 : Primary expected payer (uniform) 7,781,931 18,510 1.00 6.00 2.20 1.21 PAY2 : Secondary … OTHER O.R.PROC 1,332 0.02% 409: RADIOTHERAPY 1,032 0.01% 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 29,506 0.38% 464: SIGNS & SYMPTOMS W/O CC 8,320 0.11% 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 225 0.00% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 2,871 0.04% 467 … 0.11% 40: Multiple myeloma 3,826 0.05% 41: Cancer; other and unspecified primary 1,816 0.02% 42: Secondary

  15. Nis 2010 Maskedstats Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2010_MaskedStats_Core_Weighted.PDF
    January 01, 2010 - 0.00 1.00 0.29 0.00 PAY1 Primary expected payer (uniform) 7,781,931 18,510 1.00 6.00 2.21 0.01 PAY2 Secondary … OTHER O.R.PROC 6,725 0.02% 409: RADIOTHERAPY 5,257 0.01% 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … 147,543 0.38% 464: SIGNS & SYMPTOMS W/O CC 41,670 0.11% 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 1,113 0.00% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 14,189 0.04% … 0.12% 40: Multiple myeloma 19,277 0.05% 41: Cancer; other and unspecified primary 9,224 0.02% 42: Secondary

  16. Neds 2007 Maskedstats Ip (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007_MaskedStats_IP.PDF
    January 01, 2007 - NEOPL W OTHER O.R.PROC 195 0.01 409: RADIOTHERAPY 25 0.00 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 13,021 0.41 464: SIGNS & SYMPTOMS W/O CC 4,261 0.13 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 13 0.00 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 179 0.01 467: OTHER … DIAGNOSIS W MCC <= 10 *.** 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 110 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 13 0.00 849: RADIOTHERAPY <

  17. Kid 2009 Maskedstats Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Core_Weighted.PDF
    January 01, 2009 - 0.25 0.25 PAY1 Primary expected payer (uniform) 3,401,922 5,224 1.00 6.00 2.65 0.01 2.64 2.67 PAY2 Secondary … CC 2,865 0.04% 464: SIGNS & SYMPTOMS W/O CC 3,992 0.05% 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS <= 50 *.**% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 1,234 0.02% … 0.10% 40: Multiple myeloma <= 50 *.**% 41: Cancer; other and unspecified primary 1,985 0.03% 42: Secondary … disease) 3,683 0.05% 98: Essential hypertension 1,018 0.01% 99: Hypertension with complications and secondary

  18. Neds 2007V2 Maskedstats Ip (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007v2_MaskedStats_IP.PDF
    April 09, 2010 - NEOPL W OTHER O.R.PROC 185 0.01 409: RADIOTHERAPY 26 0.00 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 13,159 0.42 464: SIGNS & SYMPTOMS W/O CC 4,268 0.14 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 12 0.00 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 187 0.01 467: OTHER … DIAGNOSIS W MCC <= 10 *.** 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 71 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 19 0.00 849: RADIOTHERAPY <

  19. Neds 2015Q4 Ip Maskedstats (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2015Q4_IP_MaskedStats.PDF
    October 01, 2015 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 56 0.01 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 22 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 52 0.00 848 … : CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC <= 10 *.** 849: RADIOTHERAPY <= … DIAGNOSIS W MCC 22 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 52 0.00 848 … : CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC <= 10 *.** 849: RADIOTHERAPY <=

  20. Neds 2016 Ip Maskedstats (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2016_IP_MaskedStats.PDF
    January 01, 2016 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 226 0.01 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 114 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 252 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 19 0.00 849: RADIOTHERAPY 30 … DIAGNOSIS W MCC 114 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 253 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 19 0.00 849: RADIOTHERAPY 30
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (1194)

hcup-us.ahrq.gov (1163)

effectivehealthcare.ahrq.gov (808)

www.ahrq.gov (718)

digital.ahrq.gov (414)

www.uspreventiveservicestaskforce.org (380)

cds.ahrq.gov (21)

cdsic.ahrq.gov (13)

meps.ahrq.gov (7)

integrationacademy.ahrq.gov (5)

datatools.ahrq.gov (3)

qualityindicators.ahrq.gov (3)

pso.ahrq.gov (2)